Navesta Pharmaceuticals

Belkins
Accessibility of high-quality pharmaceuticals are vital for communities to be built, economies to be developed, and the world to progress. Located in Sri Lanka, Navesta Pharmaceuticals is the country's leading privately owned pharamceutical manufacturer. Specialized in the manufacturing of dry powder Beta Lactam injectables (antibiotics), Navesta’s investment into its facilities and people ensure the highest quality products while the company’s commitment to the future generations of the world assure that anyone, anywhere, has access to life saving pharmaceuticals.

Related News

PHARMACY MARKET

CPHI INDIA CONCLUDES THE 2021 HYBRID EDITION OF CPHI - P-MEC EXPO ALONG WITH INFORMA PHARMA INTELLIGENCE

Informa Pharma Intelligence | December 06, 2021

news image

Informa Pharma Intelligence, one of the leading business intelligence providers and knowledge partner, concluded its involvement at this year's CPhI & P-MEC Expo, a hybrid conclave hosted between 24th to 26th November 2021 at India Expo Centre – Greater Noida, New Delhi, and at the Online Conference & Networking event held between 15th to 30th November 2021. The conclave witnessed participation from key influencers and leading figures across the pharmaceutical in...

Read More

PHARMA TECH

PRESCRYPTIVE HEALTH LAUNCHES COMPREHENSIVE PHARMACY MANAGEMENT PLATFORM TO EXPAND THE SCOPE OF COMMUNITY PHARMACISTS

Prescryptive Health | October 06, 2021

news image

Healthcare technology company Prescryptive Health today announced that MyRx PRO is now operational nationwide. The pharmacy management platform allows pharmacists to digitize their business with new revenue opportunities through profitable clinical services and a deeper patient engagement experience. Today we change the course of the community pharmacist, by empowering them to expand their business and meet new customers through new services, all on our secure platfo...

Read More

FDA STUDY ASKS WHETHER DRUG NAMES CHANGE HOW CONSUMERS, DOCS VIEW MEDS

FiercePharma | January 22, 2020

news image

The FDA wants to know what, exactly, is in a drug name. Specifically, can a brand moniker determine how consumers and healthcare providers perceive the drug? So, the agency has launched a study to determine whether names sway opinions about a drug's effectiveness. Drugmakers submit their proposed names to the FDA for approval, but the companies often hire branding agencies to help create a name. The agency’s job is to make up brand names that draw relevant connections but follow FDA gu...

Read More

PHARMACY MARKET

EIRION THERAPEUTICS ANNOUNCES STRATEGIC AGREEMENT FOR HTL BIOTECHNOLOGY TO BECOME EIRION'S EXCLUSIVE BOTULINUM API MANUFACTURER

Eirion Therapeutics, Inc. | September 09, 2021

news image

Eirion Therapeutics, Inc., an aesthetic dermatology company headquartered in Woburn, Massachusetts, announced that HTL Biotechnology, the worldwide leader in biotechnology solutions using hyaluronic acid and other biopolymers, will become Eirion's exclusive botulinum active pharmaceutical ingredient (API) manufacturer. Botulinum is the active ingredient in Eirion's lead product candidate ET-01, a topical neuromodulator being developed for Crow's Feet wrinkles and prima...

Read More
news image

PHARMACY MARKET

CPHI INDIA CONCLUDES THE 2021 HYBRID EDITION OF CPHI - P-MEC EXPO ALONG WITH INFORMA PHARMA INTELLIGENCE

Informa Pharma Intelligence | December 06, 2021

Informa Pharma Intelligence, one of the leading business intelligence providers and knowledge partner, concluded its involvement at this year's CPhI & P-MEC Expo, a hybrid conclave hosted between 24th to 26th November 2021 at India Expo Centre – Greater Noida, New Delhi, and at the Online Conference & Networking event held between 15th to 30th November 2021. The conclave witnessed participation from key influencers and leading figures across the pharmaceutical in...

Read More
news image

PHARMA TECH

PRESCRYPTIVE HEALTH LAUNCHES COMPREHENSIVE PHARMACY MANAGEMENT PLATFORM TO EXPAND THE SCOPE OF COMMUNITY PHARMACISTS

Prescryptive Health | October 06, 2021

Healthcare technology company Prescryptive Health today announced that MyRx PRO is now operational nationwide. The pharmacy management platform allows pharmacists to digitize their business with new revenue opportunities through profitable clinical services and a deeper patient engagement experience. Today we change the course of the community pharmacist, by empowering them to expand their business and meet new customers through new services, all on our secure platfo...

Read More
news image

FDA STUDY ASKS WHETHER DRUG NAMES CHANGE HOW CONSUMERS, DOCS VIEW MEDS

FiercePharma | January 22, 2020

The FDA wants to know what, exactly, is in a drug name. Specifically, can a brand moniker determine how consumers and healthcare providers perceive the drug? So, the agency has launched a study to determine whether names sway opinions about a drug's effectiveness. Drugmakers submit their proposed names to the FDA for approval, but the companies often hire branding agencies to help create a name. The agency’s job is to make up brand names that draw relevant connections but follow FDA gu...

Read More
news image

PHARMACY MARKET

EIRION THERAPEUTICS ANNOUNCES STRATEGIC AGREEMENT FOR HTL BIOTECHNOLOGY TO BECOME EIRION'S EXCLUSIVE BOTULINUM API MANUFACTURER

Eirion Therapeutics, Inc. | September 09, 2021

Eirion Therapeutics, Inc., an aesthetic dermatology company headquartered in Woburn, Massachusetts, announced that HTL Biotechnology, the worldwide leader in biotechnology solutions using hyaluronic acid and other biopolymers, will become Eirion's exclusive botulinum active pharmaceutical ingredient (API) manufacturer. Botulinum is the active ingredient in Eirion's lead product candidate ET-01, a topical neuromodulator being developed for Crow's Feet wrinkles and prima...

Read More